Vanda Pharmaceuticals VNDA Stock Analysis 172 Loss Key Levels 20260516 Oxford OXSQ Declines 489 Amid Market Weakness 20260515 Alibaba Shares Advance as Company Strikes Bullish Tone on AI Spending Despite Profit Decline Potential TrumpXi Summit Critical Minerals and Tech Access Could Define Talks